Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
50.2B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.5B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
292.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.2B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
244.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.1B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Kyung Nam Pharm Co Ltd
Glance View
Kyungnam Pharm Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Uiryeong-Gun, Gyeongsangnam-Do. The company went IPO on 2001-11-06. The firm's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The firm provides vitamin products under the brand name LEMONA. The company supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Kyung Nam Pharm Co Ltd is 27%, which is below its 3-year median of 29.2%.
Over the last 3 years, Kyung Nam Pharm Co Ltd’s Gross Margin has increased from 26.6% to 27%. During this period, it reached a low of 26.4% on Sep 30, 2024 and a high of 32.5% on Dec 31, 2023.
